Stephanie Lim

Dr. Stephanie Lim

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Vincent HoVincent Ho
Vincent Ho
LCLiping Chung
Liping Chung
ASAmandeep Singh
Amandeep Singh
VLVivienne Lea
Vivienne Lea
AAAskar Abubakar
Askar Abubakar
C. Soon LeeC. Soon Lee
C. Soon Lee
The MRE11/RAD50/NBS1 (MRN) complex plays an essential role in detecting and repairing double-stranded breaks, and thus the potential roles of MRE11, RAD50 and NBS1 proteins in the pathogenesis of various cancers is the subject of investigation. This study was aimed at assessing the three-protein panel of MRN complex subunits as a potential radiosensitivity marker and evaluating the prognostic and clinicopathological implications of MRN expression in rectal cancer. Samples from 265 rectal cancer patients treated with surgery and adjuvant chemoradiotherapy, including samples from 55 patients who were treated with neoadjuvant radiotherapy between 2000 and 2011, were analyzed. Expression of MRN complex proteins in tissue samples was determined by immunohistochemistry. Univariate and multivariate analyses were carried out to identify clinicopathological characteristics that are associated with the MRN three-protein panel expression in rectal cancer samples. In Kaplan–Meier survival analyses, we found that high level expression of MRN complex proteins in postoperative samples was associated with poor disease-free (p = 0.021) and overall (P = 0.002) survival. Interestingly, high MRN expression also correlated with poor disease-free (P = 0.047) and overall (P = 0.024) survival in the neoadjuvant radiotherapy subgroup. In multivariate analysis, combined MRN expression (hazard ratio = 2.114, 95% confidence interval 1.096–4.078, P = 0.026) and perineural invasion (hazard ratio = 2.160, 95% confidence interval 1.209–3.859, P = 0.009) were significantly associated with a worse disease-free survival. Expression levels of MRN complex proteins significantly predict disease-free survival in rectal cancer patients, including those treated with neoadjuvant radiotherapy, and may have value in the management of these patients.

1 April 2014 in Cancer Letters
Verified
Journal Article
Closed access
SLStephanie Lim
Stephanie Lim
Therese BeckerTherese Becker
Therese Becker
WCW. Chua
W. Chua
NCN.J. Caixeiro
N.J. Caixeiro
WNW.L. Ng
W.L. Ng
KSKevin Spring
Kevin Spring

5 June 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TTThein Tut
Thein Tut
SLStephanie Lim
Stephanie Lim
IDI. U. Dissanayake
I. U. Dissanayake
JDJ. Descallar
J. Descallar
WCW. Chua
W. Chua
C. Soon LeeC. Soon Lee
C. Soon Lee
Human polo-like kinase 1 (PLK1) expression has been associated with inferior outcomes in colorectal cancer. Our aims were to analyse PLK1 in rectal cancer, and its association with clinicopathological variables, overall survival as well as tumour regression to neoadjuvant treatment. PLK1 expression was quantified with immunohistochemistry in the centre and periphery (invasive front) of rectal cancers, as well as in the involved regional lymph nodes from 286 patients. Scores were based on staining intensity and percentage of positive cells, multiplied to give weighted scores from 1–12, dichotomised into low (0–5) or high (6–12). PLK1 scores in the tumour periphery were significantly different to adjacent normal mucosa. Survival analysis revealed that low PLK1 score in the tumour periphery had a hazard ratio of death of 0.59 in multivariate analysis. Other predictors of survival included age, tumour depth, metastatic status, vascular and perineural invasion and adjuvant chemotherapy. There was no statistically significant correlation between PLK1 score and histological tumour regression in the neoadjuvant cohort. Low PLK1 score was an independent predictor of superior overall survival, adjusting for multiple clinicopathological variables including treatment.

1 October 2015 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
SLStephanie Lim
Stephanie Lim
WCW. Chua
W. Chua
CHC. Henderson
C. Henderson
WNWeng Ng
Weng Ng
JSJ.-S. Shin
J.-S. Shin
PSP. de Souza
P. de Souza

1 August 2014 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
SLStephanie Lim
Stephanie Lim
SASimone Ardern-Holmes
Simone Ardern-Holmes
GMGeoffrey McCowage
Geoffrey McCowage
PSPaul de Souza
Paul de Souza

1 November 2014
Verified
Journal Article
Closed access
SLStephanie Lim
Stephanie Lim
WCWei Chua
Wei Chua
CCChristina Cheng
Christina Cheng
JDJoseph Descallar
Joseph Descallar
WNWeng Ng
Weng Ng
C. Soon LeeC. Soon Lee
C. Soon Lee